D. Eric Mendelsohn's most recent trade in National Health Investors, Inc. was a trade of 130,461 Common Stock done at an average price of $82.1 . Disclosure was reported to the exchange on Sept. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.10 per share. | 05 Sep 2024 | 130,461 | 88,794 (0%) | 0% | 82.1 | 10,710,848 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 41,668 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 05 Sep 2024 | 41,668 | 219,255 (0%) | 0% | 53.4 | 2,225,488 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 41,666 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 41,666 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 05 Sep 2024 | 41,666 | 177,587 (0%) | 0% | 53.4 | 2,225,381 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 05 Sep 2024 | 41,666 | 135,921 (0%) | 0% | 53.4 | 2,225,381 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 13,333 | 0 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 13,333 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 13,333 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 05 Sep 2024 | 13,333 | 94,255 (0%) | 0% | 57.8 | 770,114 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 05 Sep 2024 | 13,333 | 80,922 (0%) | 0% | 54.7 | 729,715 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 05 Sep 2024 | 13,333 | 67,589 (0%) | 0% | 54.7 | 729,715 | Common Stock |
| National Health Investors,... | Mendelsohn D. Eric | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 13,334 | 13,334 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | D. Mendelsohn Eric | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | Eric Mendelsohn D. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,000 | 54,256 (0%) | 0% | 0 | Common Stock | |
| National Health Investors,... | D. Eric Mendelsohn | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 5,000 | 51,256 (0%) | 0% | 0 | Common Stock | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 13,334 | 13,334 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 41,668 | 41,668 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 41,666 | 41,666 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 41,666 | 41,666 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Purchase of securities on an exchange or from another person at price $ 54.34 per share. | 29 Sep 2021 | 1,000 | 45,256 (0%) | 0% | 54.3 | 54,339 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Purchase of securities on an exchange or from another person at price $ 54.42 per share. | 29 Sep 2021 | 874 | 46,256 (0%) | 0% | 54.4 | 47,563 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Purchase of securities on an exchange or from another person at price $ 54.40 per share. | 29 Sep 2021 | 106 | 45,382 (0%) | 0% | 54.4 | 5,766 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Purchase of securities on an exchange or from another person at price $ 54.40 per share. | 29 Sep 2021 | 20 | 45,276 (0%) | 0% | 54.4 | 1,088 | Common Stock |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 41,668 | 41,668 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 41,666 | 41,666 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | D. Eric Mendelsohn | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 41,666 | 41,666 | - | - | Stock Options (Right to Buy) 2-25-2021 |